In yesterday’s Wall Street session, Cano Health Inc (NYSE:CANO) shares traded at $0.26, down -0.12% from the previous session.
6 analysts cover Cano Health Inc (NYSE:CANO), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $2.00 and a low of $0.50, we find $0.65. Given the previous closing price of $0.26, this indicates a potential upside of 150.0 percent. CANO stock price is now -57.90% away from the 50-day moving average and -77.60% away from the 200-day moving average. The market capitalization of the company currently stands at $72.88M.
The stock has received a hold rating from 4 analysts and a buy rating from 1. Brokers who have rated the stock have averaged $0.95 as their price target over the next twelve months.
In other news, Camerlinck Robert, Chief Operating Officer sold 30,646 shares of the company’s stock on Aug 11. The stock was sold for $23,453 at an average price of $0.77. Upon completion of the transaction, the Chief Operating Officer now directly owns 26,958,642 shares in the company, valued at $7.01 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 29, Chief Clinical Officer Aguilar Richard sold 400,000 shares of the business’s stock. A total of $525,760 was realized by selling the stock at an average price of $1.31. This leaves the insider owning 1,213,984 shares of the company worth $0.32 million. Insiders disposed of 11,704,536 shares of company stock worth roughly $3.04 million over the past 1 year. A total of 25.28% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CANO stock. A new stake in Cano Health Inc shares was purchased by NORGES BANK during the first quarter worth $674,000. LEVIN CAPITAL STRATEGIES, L.P. invested $78,000 in shares of CANO during the first quarter. In the first quarter, WALLEYE CAPITAL LLC acquired a new stake in Cano Health Inc valued at approximately $29,000. TWO SIGMA INVESTMENTS, LP acquired a new stake in CANO for approximately $21,000. STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM purchased a new stake in CANO valued at around $17,000 in the second quarter. In total, there are 209 active investors with 47.36% ownership of the company’s stock.
On Thursday morning Cano Health Inc (NYSE: CANO) stock kicked off with the opening price of $0.2550. During the past 12 months, Cano Health Inc has had a low of $0.22 and a high of $9.75. As of last week, the company has a debt-to-equity ratio of 8.39, a current ratio of 0.49, and a quick ratio of 0.49. The fifty day moving average price for CANO is $0.5838 and a two-hundred day moving average price translates $1.1347 for the stock.
The latest earnings results from Cano Health Inc (NYSE: CANO) was released for Jun, 2023. According to the Medical Care Facilities Company, earnings per share came in at -$0.51, missing analysts’ expectations of -$0.12 by -0.39. This compares to -$0.03 EPS in the same period last year. The net profit margin was -12.47% and return on equity was -132.92% for CANO. The company reported revenue of $766.75 million for the quarter, compared to $689.37 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.22 percent. For the current quarter, analysts expect CANO to generate $775.33M in revenue.
Cano Health Inc(CANO) Company Profile
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
